Indian pharmaceutical stocks witnessed a decline as Donald Trump issued a warning about imposing tariffs on pharmaceutical imports. The Nifty Pharma index dropped by 1.7%, with key players such as Gland Pharma and Sun Pharma witnessing notable decreases in their stock values. Trump’s remarks emphasized the push for pharmaceutical companies to relocate their production to the United States by implementing tariffs, which could potentially affect India’s extensive generic drug exports to the US.